Last 1,437 GBp
Change Today +2.50 / 0.17%
Volume 6.3M
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
London
Mexico
Frankfurt
As of 11:35 AM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Moncef M. Slaoui Ph.D.

Chairman of Global R&D & Vaccines, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee, GlaxoSmithKline plc
AgeTotal Calculated CompensationThis person is connected to 34 board members in 3 different organizations across 3 different industries.

See Board Relationships
54$8,414,000
As of Fiscal Year 2013

Background*

Dr. Moncef M. Slaoui, Ph.D., serves as the Chairman of Global Research and Development and Vaccines at GlaxoSmithKline PLC. Dr. Slaoui serves as a Member of the Corporate Executive Team of GlaxoSmithKline, PLC. He served as the Chairman of Research and Development at GlaxoSmithKline PLC since June 1, 2006 and leads the complex drug discovery and development activities. Dr. Slaoui served as the Chairman of Research & Development at Glaxosmithkline Biologicals S.A. He ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Former Director
Director and Member of Strategic Advisory Board
2006-Present
Chairman of Global R&D & Vaccines, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee

Education*

Unknown/Other Education
Harvard Medical School
Unknown/Other Education
Tufts University School of Medicine
PhD
Universite Libre de Bruxelles in Belgium

Other Affiliations*

Annual Compensation*

Salary$1,180,000
Bonus$1,973,000
Total Annual Compensation$3,153,000

Stock Options*

Restricted Stock Awards$4,248,000
All Other Compensation$1,013,000
Exercised Options25,981
Exercised Options Value388,416 GBP
Total Value of Options686,404 GBP
Total Number of Options125,536

Total Compensation*

Total Annual Cash Compensation$4,166,000
Total Short Term Compensation$3,153,000
Other Long Term Compensation$5,261,000
Total Calculated Compensation$8,414,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,436.50 GBp +2.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.